Table 2 Comparison of the preoperative clinical data between the two groups
Preoperative data | Low-priming-volume group (group A, n = 79) | Traditional group (group B, n = 79) | p value |
|---|---|---|---|
male/case | 48 | 48 | |
age/month (range) | 1 ~ 48 (13.66 ± 12.59) | 1.5 ~ 48 (14.51 ± 13.31) | 0.681 |
body weight/kg (range) | 4 ~ 15 (8.62 ± 3.31) | 4 ~ 15 (8.91 ± 3.35) | 0.859 |
main diagnostic/case | |||
ASD(+PDA) | 7 | 3 | |
ASD + PS(+PDA) | 9 | 7 | |
VSD(+PDA) | 29 | 28 | |
VSD + PS | 5 | 0 | |
VSD + ASD(+PDA) | 27 | 29 | |
PS | 0 | 5 | |
PAPVC+ASD | 1 | 4 | |
PECD | 0 | 1 | |
TOF | 1 | 2 | |
EF/% | 69.46 ± 6.19 | 69.88 ± 6.97 | 0.689 |
WBCs/(10*9/L) | 9.13 ± 2.67 | 8.64 ± 2.48 | 0.240 |
neutrophil percentage/% | 29.49 ± 12.28 | 31.91 ± 12.55 | 0.230 |
Hb/(g/dL) | 11.88 ± 1.67 | 12.18 ± 1.81 | 0.280 |
platelets/(10*9/L) | 338.62 ± 89.67 | 332.72 ± 110.86 | 0.718 |
CRP/(mg/L) | 0.93 ± 1.95 | 0.62 ± 0.95 | 0.198 |
blood glucose/(mmol/L) | 4.68 ± 0.81 | 4.68 ± 0.88 | 0.950 |
total bilirubin/(μmol/L) | 7.17 ± 5.27 | 9.01 ± 9.27 | 0.134 |
creatinine/(μmol/L) | 24.31 ± 8.95 | 24.41 ± 6.08 | 0.937 |